Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy

NCT03220178 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

532

Enrollment

INDUSTRY

Sponsor class

Stopped Due to COVID-19 pandemic, study cannot be finished in planned timeframe.

Conditions

Breast Neoplasm

Interventions

DRUG: Palbociclib
DRUG: Fulvestrant
DRUG: Anastrozole
DRUG: Letrozole
DRUG: Exemestane

Sponsor

Palleos Healthcare GmbH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]